Mural Health & ProofPilot Partner to Advance Clinical Trial Operations

medical news© Jae Young Ju / Getty Images / Canva

BERWYN, PA — Mural Health and ProofPilot recently announced a strategic partnership to further advance clinical trial operations for life science customers. Through this partnership, Mural Health’s Mural Link™ platform and ProofPilot‘s platform work together to progress clinical operations and materially improve the efficiency, and outcomes, of global clinical trials.

Rigorous participant compliance in research is driven by the ability to responsibly incentivize the successful and timely completion of specific tasks. A well-designed, modern payment model serves as a key lynchpin to round out a comprehensive solution.

Adding to the growing list of partners brought into ProofPilot’s digital protocol automation platform, Mural Health provides sponsors and sites another automated, turnkey capability, further reducing site burden while providing more optionality for patients.

Mural Health’s CEO and Founder, Sam Whitaker has a proven record of revolutionizing payment models for clinical research participants: “Through our Mural Link Platform, we have again revolutionized participant payments to drive strategic value to a study by genuinely making the participant’s experience easier through a wide range of payment options. The platform radically increases the efficiency of in-person and remote patient and site experiences in two ways: eliminating the requirement of distributing physical debit cards and automating disbursement of payments linked to completed tasks. While our model works exceptionally well for brick-and-mortar trials, it is also especially relevant in a DCT context as well,” said Sam. “We are excited to partner with ProofPilot, creating a complementary, next generation digital protocol automation ecosystem to deliver a wide variety of integrated functions to our mutual customers.”

“At ProofPilot, we have always seen a higher degree of patient compliance when payments can be automated and closely tied to a wide variety of tasks. Most are unaware of the number of hidden activities needed for a patient to execute during a study outside of the explicit tasks,” said Chris Venezia, CEO of ProofPilot. “Through the strategic partnership of our digital protocol automation platform, along with Mural Health’s participant payment capabilities, we will make it easier for our sites and patients to successfully conduct and participate in research by increasing the efficiency to complete tasks, procedures, and now, patient payments.”

READ:  STRATA Skin Sciences Announces First Patients Treated in TheraClear®X Clinical Study for Acne

Whitaker added, “I am thrilled to see our companies working together to deliver a market-leading protocol automation platform.”

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News.